Warrants TO1 and TO2 are now registered with the Swedish Companies Registration Office. Conversion of interim shares to ordinary shares will take place on February 29, 2016. The result means that 3,812,962 shares were acquired by warrant holders and the Company received approximately SEK 11.4 million in cash. For inquiries regarding the warrants, please contact: Aktieinvest FK AB Tel: +46 (0)8-5065 1700 e-mail: kundservice@aktieinvest.se Other questions? Please contact: Henrik Norström, COO Phone: 46 733 40 30 45 henrik.norstrom@brighter.se Truls Sjöstedt, CEO Phone: 46 709 73 46 00 truls.sjostedt@brighter.se About Brighter AB (publ). Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and innovative tools, jDome® and Actiste™, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop ™, Brighter’s cloud -based service that continuously collects, analyzes and shares data on the user's terms. The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Corporate Finance +46 (0)8 – 454 32 76, CorporateFinance@remium.com, www.remium.com.
Warrants TO1 and TO2 are now registered with the Swedish Companies Registration Office.
| Source: Brighter AB
Attachments
